TRUIST FINANCIAL CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that TRUIST FINANCIAL CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.74B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $2.16B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $8.63B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $11.08B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $7.89B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $7.44B | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $1.52B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $4.35B | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $4.64B | Mar 3, 2020 |
| FY2018 | Dec 31, 2016 | $3.12B | Feb 26, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $564.00M | Feb 28, 2023 |
| FY2022 | Dec 31, 2021 | $442.00M | Feb 28, 2023 |
| FY2022 | Dec 31, 2020 | $815.00M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $224.00M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $363.00M | Feb 24, 2021 |
| FY2012 | Dec 31, 2012 | $145.00M | Mar 1, 2013 |
| FY2012 | Dec 31, 2011 | $224.00M | Mar 1, 2013 |
| FY2012 | Dec 31, 2010 | $428.00M | Mar 1, 2013 |
| FY2009 | Dec 31, 2009 | $174.00M | Feb 26, 2010 |
| FY2010 | Dec 31, 2008 | $219.00M | Feb 25, 2011 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $547.54B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $531.18B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $535.35B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $555.26B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $541.24B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $509.23B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $473.08B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $225.70B | Mar 3, 2020 |
| FY2018 | Dec 31, 2017 | $221.64B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $219.28B | Feb 21, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $482.35B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $467.50B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $476.10B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $494.72B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $471.97B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $438.32B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $406.52B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $195.52B | Mar 3, 2020 |
| FY2018 | Dec 31, 2017 | $191.95B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $189.35B | Feb 21, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $65.19B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $63.68B | Feb 24, 2026 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.13B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $17.13B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $17.16B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $23.23B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $26.10B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $24.45B | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $24.15B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $9.82B | Feb 24, 2021 |
| FY2020 | Dec 31, 2017 | $9.62B | Feb 24, 2021 |
| FY2018 | Dec 31, 2016 | $9.64B | Feb 26, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.07B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $23.78B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $22.09B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $26.26B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $23.00B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $19.46B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $19.81B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $18.12B | Mar 3, 2020 |
| FY2018 | Dec 31, 2017 | $16.26B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $14.81B | Feb 21, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $20.30B | Feb 23, 2022 |
| FY2021 | Dec 31, 2020 | $18.87B | Feb 23, 2022 |
| FY2021 | Dec 31, 2019 | $19.07B | Feb 23, 2022 |
| FY2021 | Dec 31, 2018 | $3.84B | Feb 23, 2022 |
| FY2020 | Dec 31, 2017 | $2.96B | Feb 24, 2021 |
| FY2019 | Dec 31, 2016 | $4.28B | Mar 3, 2020 |
| FY2018 | Dec 31, 2015 | $4.17B | Feb 26, 2019 |
| FY2017 | Dec 31, 2014 | $2.33B | Feb 21, 2018 |
| FY2016 | Dec 31, 2013 | $2.17B | Feb 21, 2017 |
| FY2015 | Dec 31, 2012 | $3.04B | Feb 25, 2016 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $41.96B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $34.96B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $38.92B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $43.20B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $35.91B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $39.60B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $41.34B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $23.71B | Mar 3, 2020 |
| FY2018 | Dec 31, 2017 | $23.65B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $21.97B | Feb 21, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 4 | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | 3 | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | 3 | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | 3 | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | 2 | Mar 3, 2020 |
| FY2018 | Dec 31, 2016 | 2 | Feb 26, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 4 | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | 3 | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | 3 | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | 3 | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | 2 | Mar 3, 2020 |
| FY2018 | Dec 31, 2016 | 2 | Feb 26, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.26B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 1.32B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | 1.33B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | 1.33B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | 1.33B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | 1.35B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | 1.34B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | 763.33M | Mar 3, 2020 |
| FY2018 | Dec 31, 2017 | 782.01M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | 809.48M | Feb 21, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.67B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $2.77B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $2.77B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $2.66B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $2.49B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $2.42B | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $1.31B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $1.20B | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $1.01B | Mar 3, 2020 |
| FY2018 | Dec 31, 2016 | $925.00M | Feb 26, 2019 |